Category: Oncology/Hematology
Global Oncology/Hematology
-
Global Hairy Cell Leukemia Therapeutics Market 2024-2028
... on the hairy cell leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Cancer Cachexia Global Market Report 2024
... Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA Cancer Cachexia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024
... Assays3) By Therapeutic Area: Lung Cancer; Breast Cancer; MelanomaCovering: Thermo Fisher Scientific Inc.; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE; WuXi AppTec Co Ltd. Cancer Immunotherapy Drug Discovery Outsourcing Global Market ... Read More
-
Antisense And RNAi Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Cardiometabolic & Renal Disorders, Cancer, Respiratory Disorders, Skin Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases), By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other), By Region and Competition, 2019-2029F
... Disorders, Infectious Diseases), By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other), By Region and Competition, 2019-2029F Global Antisense And RNAi Therapeutics Market was valued at USD 4.57 billion in 2023 and is ... Read More
-
Global Multiple Myeloma Drugs Market 2024-2028
... multiple myeloma drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Cancer Immunotherapy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Application (Cancer, Neurodegenerative Disorders), Source (Bone Marrow, Mesenchymal Stem Cells), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Growth & Trends The global autologous cell therapy market size is expected to reach USD 17.97 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030
... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
-
Lymphoma Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More
-
Prescription Drugs
... at a CAGR of 5.7% over the analysis period 2023-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$498.0 Billion by the end of the ... Read More
-
Cancer Therapies
... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More
-
Brachytherapy
... of 4.4% over the analysis period 2023-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Lung Cancer Diagnostics
... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.3 Billion by ... Read More
-
Colorectal Cancer Therapeutics
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by ... Read More
-
Bladder Cancer Therapeutics
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Transitional Cell Bladder Cancer Therapeutics, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach ... Read More
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
... projected to reach USD 105 million by 2029 from USD 80 million in 2024, at a CAGR of 5.5% during the forecast period of 2024 to 2029. The market is experiencing an upward trend driven ... Read More
-
Bulk Paclitaxel
... at a CAGR of 8.6% over the analysis period 2023-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$139.1 Million by the end ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
-
Breast Cancer Therapeutics
... by 2030, growing at a CAGR of 12.3% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by ... Read More
-
Prostate Cancer Therapeutics
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by ... Read More
-
Global Digital Thoracic Drainage Devices Market: Analysis By Type (Single Chamber, and Multiple Chamber), By Application (Thoracic & Pulmonary Surgery, Infectious Diseases, Oncology & Trauma, Cardiac Surgery, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Surgical Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count ... Read More
Research Assistance
